230 related articles for article (PubMed ID: 12663780)
1. Human cytomegalovirus US3 chimeras containing US2 cytosolic residues acquire major histocompatibility class I and II protein degradation properties.
Chevalier MS; Johnson DC
J Virol; 2003 Apr; 77(8):4731-8. PubMed ID: 12663780
[TBL] [Abstract][Full Text] [Related]
2. Binding of human cytomegalovirus US2 to major histocompatibility complex class I and II proteins is not sufficient for their degradation.
Chevalier MS; Daniels GM; Johnson DC
J Virol; 2002 Aug; 76(16):8265-75. PubMed ID: 12134032
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the MHC class II antigen presentation pathway by human cytomegalovirus.
Johnson DC; Hegde NR
Curr Top Microbiol Immunol; 2002; 269():101-15. PubMed ID: 12224504
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation.
Hegde NR; Tomazin RA; Wisner TW; Dunn C; Boname JM; Lewinsohn DM; Johnson DC
J Virol; 2002 Nov; 76(21):10929-41. PubMed ID: 12368336
[TBL] [Abstract][Full Text] [Related]
5. Human cytomegalovirus US2 causes similar effects on both major histocompatibility complex class I and II proteins in epithelial and glial cells.
Hegde NR; Johnson DC
J Virol; 2003 Sep; 77(17):9287-94. PubMed ID: 12915544
[TBL] [Abstract][Full Text] [Related]
6. TRAM1 participates in human cytomegalovirus US2- and US11-mediated dislocation of an endoplasmic reticulum membrane glycoprotein.
Oresic K; Ng CL; Tortorella D
J Biol Chem; 2009 Feb; 284(9):5905-14. PubMed ID: 19121997
[TBL] [Abstract][Full Text] [Related]
7. Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains.
Jones TR; Wiertz EJ; Sun L; Fish KN; Nelson JA; Ploegh HL
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11327-33. PubMed ID: 8876135
[TBL] [Abstract][Full Text] [Related]
8. The p97 ATPase dislocates MHC class I heavy chain in US2-expressing cells via a Ufd1-Npl4-independent mechanism.
Soetandyo N; Ye Y
J Biol Chem; 2010 Oct; 285(42):32352-9. PubMed ID: 20702414
[TBL] [Abstract][Full Text] [Related]
9. Structural and functional analysis of human cytomegalovirus US3 protein.
Misaghi S; Sun ZY; Stern P; Gaudet R; Wagner G; Ploegh H
J Virol; 2004 Jan; 78(1):413-23. PubMed ID: 14671122
[TBL] [Abstract][Full Text] [Related]
10. Structural and functional dissection of human cytomegalovirus US3 in binding major histocompatibility complex class I molecules.
Lee S; Yoon J; Park B; Jun Y; Jin M; Sung HC; Kim IH; Kang S; Choi EJ; Ahn BY; Ahn K
J Virol; 2000 Dec; 74(23):11262-9. PubMed ID: 11070025
[TBL] [Abstract][Full Text] [Related]
11. The role of BiP in endoplasmic reticulum-associated degradation of major histocompatibility complex class I heavy chain induced by cytomegalovirus proteins.
Hegde NR; Chevalier MS; Wisner TW; Denton MC; Shire K; Frappier L; Johnson DC
J Biol Chem; 2006 Jul; 281(30):20910-20919. PubMed ID: 16731524
[TBL] [Abstract][Full Text] [Related]
12. Human cytomegalovirus-encoded US2 and US11 target unassembled MHC class I heavy chains for degradation.
Barel MT; Hassink GC; van Voorden S; Wiertz EJ
Mol Immunol; 2006 Mar; 43(8):1258-66. PubMed ID: 16098592
[TBL] [Abstract][Full Text] [Related]
13. Membrane-specific, host-derived factors are required for US2- and US11-mediated degradation of major histocompatibility complex class I molecules.
Furman MH; Ploegh HL; Tortorella D
J Biol Chem; 2002 Feb; 277(5):3258-67. PubMed ID: 11717308
[TBL] [Abstract][Full Text] [Related]
14. Endoplasmic reticulum chaperones participate in human cytomegalovirus US2-mediated degradation of class I major histocompatibility complex molecules.
Oresic K; Tortorella D
J Gen Virol; 2008 May; 89(Pt 5):1122-1130. PubMed ID: 18420789
[TBL] [Abstract][Full Text] [Related]
15. Human cytomegalovirus-encoded US2 differentially affects surface expression of MHC class I locus products and targets membrane-bound, but not soluble HLA-G1 for degradation.
Barel MT; Ressing M; Pizzato N; van Leeuwen D; Le Bouteiller P; Lenfant F; Wiertz EJ
J Immunol; 2003 Dec; 171(12):6757-65. PubMed ID: 14662880
[TBL] [Abstract][Full Text] [Related]
16. Subtle sequence variation among MHC class I locus products greatly influences sensitivity to HCMV US2- and US11-mediated degradation.
Barel MT; Pizzato N; Le Bouteiller P; Wiertz EJ; Lenfant F
Int Immunol; 2006 Jan; 18(1):173-82. PubMed ID: 16361314
[TBL] [Abstract][Full Text] [Related]
17. Human cytomegalovirus-encoded immune modulators partner to downregulate major histocompatibility complex class I molecules.
Noriega VM; Tortorella D
J Virol; 2009 Feb; 83(3):1359-67. PubMed ID: 19004944
[TBL] [Abstract][Full Text] [Related]
18. The HCMV gene products US2 and US11 target MHC class I molecules for degradation in the cytosol.
van der Wal FJ; Kikkert M; Wiertz E
Curr Top Microbiol Immunol; 2002; 269():37-55. PubMed ID: 12224515
[TBL] [Abstract][Full Text] [Related]
19. Signal peptide peptidase is required for dislocation from the endoplasmic reticulum.
Loureiro J; Lilley BN; Spooner E; Noriega V; Tortorella D; Ploegh HL
Nature; 2006 Jun; 441(7095):894-7. PubMed ID: 16738546
[TBL] [Abstract][Full Text] [Related]
20. Human cytomegalovirus gene products US2 and US11 differ in their ability to attack major histocompatibility class I heavy chains in dendritic cells.
Rehm A; Engelsberg A; Tortorella D; Körner IJ; Lehmann I; Ploegh HL; Höpken UE
J Virol; 2002 May; 76(10):5043-50. PubMed ID: 11967320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
